Use of surgery and chemoradiation in stage II and III rectal cancer: A retrospective comparison of treatment modalities in major insurance types using the NCDB

Autor:	Naomi Whittaker, Peter T. Silberstein, Timothy Fuller, Lauren Brin, Mary Warlaumont
Rok vydání:	2013
Předmět:	Cancer Research medicine.medical_specialty Standard of care Colorectal cancer business.industry Cancer Stage ii medicine.disease Surgery Oncology Insurance types Treatment modality medicine Private insurance business Medicaid
Zdroj:	Journal of Clinical Oncology. 31:e14641-e14641
ISSN:	1527-7755 0732-183X 2000-2009
DOI:	10.1200/jco.2013.31.15_suppl.e14641
Popis:	e14641 Background: The preferred method of care for stage II/III rectal cancer is trimodal therapy: neoadjuvant chemoradiation plus surgical resection. We aim to compare the treatment practices for patients with stage II/III rectal cancer in major insurance types. Methods: Using data from the National Cancer Database (NCDB), we analyzed the treatment patterns of 91,782 patients diagnosed with stage II/III rectal cancer from 2000-2009. The NCDB includes data from 70% of all U.S. cancer patients. This is the largest study of this kind to date. Results: In stage II/III rectal cancer, patients with private insurance received more trimodal therapy (70.3%) than patients with VA Insurance (56.6%), Medicare (46.9%), Medicaid (66.5%), or no insurance (61.7%) (p
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40e1a002866104c615727b488a5eec63 https://doi.org/10.1200/jco.2013.31.15_suppl.e14641 Zobrazit plný text záznamu